Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | FLT3 | P36888 | 4/20 | 0.84 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.80 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.80 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.80 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.80 |
| ▸ | MEN1 | O00255 | 4/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.79 |
| ▸ | NPC1 | O15118 | 2/20 | 0.79 |
| ▸ | RAB9A | P51151 | 2/20 | 0.79 |
| ▸ | GABRP | O00591 | 1/20 | 0.79 |
| ▸ | GABRD | O14764 | 1/20 | 0.79 |
| ▸ | PIM1 | P11309 | 1/20 | 0.79 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.79 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.79 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.79 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cirsimaritin SCHEMBL29459674 | 1.00 | POLB (1.00) | POLBMAPTKDM4EADORA3FLT3 | |
| SCHEMBL735537 | 0.92 | MAPT (0.85) | POLBMAPTKDM4EADORA3FLT3 | |
| Salvigenin SCHEMBL1427018 | 0.91 | FLT3 (1.00) | POLBMAPTKDM4EADORA3FLT3 | |
| SCHEMBL28040107 | 0.91 | POLB (1.00) | POLBMAPTKDM4EADORA3FLT3 | |
| SCHEMBL17258303 | 0.90 | POLB (0.82) | POLBMAPTKDM4EADORA3FLT3 | |
| Mosloflavone SCHEMBL971985 | 0.90 | KDM4E (0.81) | POLBMAPTKDM4EADORA3FLT3 | |
| Mosloflavone SCHEMBL29477310 | 0.90 | KDM4E (0.81) | POLBMAPTKDM4EADORA3FLT3 | |
| SCHEMBL739122 | 0.90 | POLB (0.83) | POLBMAPTKDM4EADORA3FLT3 | |
| SCHEMBL34468184 | 0.89 | CYP1B1 (1.00) | POLBMAPTKDM4EADORA3FLT3 | |
| SCHEMBL31238120 | 0.89 | CYP1B1 (1.00) | POLBMAPTKDM4EADORA3FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 417 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| WO-2025199801-A1 | COMPOSITION FOR TREATING RENAL DYSFUNCTION-ASSOCIATED DIABETIC FOOT ULCERS IN SUBJECT | 合一生技股份有限公司 | 2025-10-02 | — | — | WO | claimed |
| EP-4595768-A2 | PET FOOD COMPOSITIONS | Hill's Pet Nutrition, Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| EP-4543425-A1 | PLECTRANTHUS AMBOINICUS EXTRACT FOR USE IN ALLEVIATION OF RADIATION-INDUCED SKIN DISORDERS | Oneness Biotech Co., Ltd. (TW) | 2025-04-30 | — | — | EP | claimed |
| EP-3397069-B1 | PET FOOD COMPOSITIONS | HILLS PET NUTRITION INC (US) | 2025-04-16 | — | — | EP | claimed |
| EP-4531841-A1 | PLECTRANTHUS AMBOINICUS EXTRACT FOR USE IN INHIBITING IMMUNE RESPONSES | Oneness Biotech Co., Ltd. (TW) | 2025-04-09 | — | — | EP | claimed |
| WO-2024220449-A9 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2025-04-03 | — | — | WO | claimed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | claimed |
| US-20250011393-A1 | FLAVONOID-COLLAGEN CROSSLINKED ANTIOXIDANT HYDROGEL | NORTH CAROLINA STATE UNIVERSITY | 2025-01-09 | — | — | US | claimed |
| US-20240390504-A1 | MULTIFUNCTIONAL CONJUGATES | E P O S IASIS RES AND DEVELOPMENT LIMITED (CY) | 2024-11-28 | — | — | US | claimed |
| US-20140017341-A1 | COMPOSITION AND METHOD FOR TREATING FAT TISSUES AND INFLAMMATORY PROCESSES | GOURLAOUEN BRIGITTE (FR) | 2014-01-16 | — | — | US | claimed |
| CN-103420967-A | Preparation method for marina thistle flavin | NANJING BIAOKE BIO TECHNOLOGY CO LTD | 2013-12-04 | — | — | CN | claimed |
| CN-103127215-A | Extract of joss-stick having anti-arthritic activity | ONENESS BIOTECH CO | 2013-06-05 | — | — | CN | claimed |
| US-20110160136-A1 | POLYPHENOLS FOR THE TREATMENT OF CARTILAGE DISORDERS | NESTEC S.A. (CH) | 2011-06-30 | — | — | US | claimed |
| EP-2247290-A1 | POLYPHENOLS FOR THE TREATMENT OF CARTILAGE DISORDERS | Nestec S.A. (CH) | 2010-11-10 | — | — | EP | claimed |
| WO-2009106125-A1 | POLYPHENOLS FOR THE TREATMENT OF CARTILAGE DISORDERS | NESTEC S.A. (CH) | 2009-09-03 | — | — | WO | claimed |
| US-20060115502-A1 | Cosmetic composition based on cirsimarin | GATTEFOSSE SAS (FR) | 2006-06-01 | — | — | US | claimed |
| US-6471973-B2 | DRUGS, COSMETICS, DIETETICS, AGRICULTURE | COLETICA (FR) | 2002-10-29 | — | — | US | claimed |
| US-6451837-B1 | Neuroprotective effects of mitogen-activated protein kinase (MAPK) cascade inhibitors | BASKYS ANDRIUS (US) | 2002-09-17 | — | — | US | claimed |
| US-20010031735-A1 | Flavonoide esters and their use notably in cosmetics | COLETICA (FR) | 2001-10-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160136-A1 | POLYPHENOLS FOR THE TREATMENT OF CARTILAGE DISORDERS | COL2A1, MTPN, CPT1B | POLB 1729/4885MAPT 2938/4885KDM4E 535/4885 |
| US-20010031735-A1 | Flavonoide esters and their use notably in cosmetics | TYR, MITF, CYP2F1 | POLB 3446/4885MAPT 2248/4885KDM4E 512/4885 |
| US-20060115502-A1 | Cosmetic composition based on cirsimarin | PLIN1, PLIN3, PLIN5 | POLB 1970/4885MAPT 4178/4885KDM4E 3754/4885 |
| US-20240390504-A1 | MULTIFUNCTIONAL CONJUGATES | MKI67, ACP3, CD44 | POLB 2600/4885MAPT 3085/4885KDM4E 2798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.